1. Home
  2. NKGN vs ARBB Comparison

NKGN vs ARBB Comparison

Compare NKGN & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • ARBB
  • Stock Information
  • Founded
  • NKGN 2017
  • ARBB 1997
  • Country
  • NKGN United States
  • ARBB Singapore
  • Employees
  • NKGN N/A
  • ARBB N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • ARBB EDP Services
  • Sector
  • NKGN Health Care
  • ARBB Technology
  • Exchange
  • NKGN Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • NKGN 14.1M
  • ARBB 12.3M
  • IPO Year
  • NKGN N/A
  • ARBB 2023
  • Fundamental
  • Price
  • NKGN $0.65
  • ARBB $0.41
  • Analyst Decision
  • NKGN
  • ARBB
  • Analyst Count
  • NKGN 0
  • ARBB 0
  • Target Price
  • NKGN N/A
  • ARBB N/A
  • AVG Volume (30 Days)
  • NKGN 573.8K
  • ARBB 141.6K
  • Earning Date
  • NKGN 12-31-2024
  • ARBB 11-22-2024
  • Dividend Yield
  • NKGN N/A
  • ARBB N/A
  • EPS Growth
  • NKGN N/A
  • ARBB N/A
  • EPS
  • NKGN N/A
  • ARBB N/A
  • Revenue
  • NKGN N/A
  • ARBB $12,334,474.00
  • Revenue This Year
  • NKGN N/A
  • ARBB N/A
  • Revenue Next Year
  • NKGN N/A
  • ARBB N/A
  • P/E Ratio
  • NKGN N/A
  • ARBB N/A
  • Revenue Growth
  • NKGN N/A
  • ARBB N/A
  • 52 Week Low
  • NKGN $0.20
  • ARBB $0.22
  • 52 Week High
  • NKGN $4.06
  • ARBB $4.55
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 65.93
  • ARBB 40.44
  • Support Level
  • NKGN $0.45
  • ARBB $0.47
  • Resistance Level
  • NKGN $0.62
  • ARBB $0.50
  • Average True Range (ATR)
  • NKGN 0.08
  • ARBB 0.05
  • MACD
  • NKGN 0.01
  • ARBB -0.01
  • Stochastic Oscillator
  • NKGN 70.95
  • ARBB 12.42

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT') and Investment holding and others. It earns its maximum profit from the Internet of Things segment.

Share on Social Networks: